Indefinite Delivery Contract SPE2DX15D9647
Award Date 4/29/15
Last Date to Order 12/31/25
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed Similar IDVs
- The federal contract IDV award SPE2DX16D9902 is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $499,999,999 IDC, valid through November 2026, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical...
- The federal contract IDV award described is a single-award Indefinite Delivery Contract (IDC) valued at $4,999,999.00 and awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, under the SPE2DX program, has an ultimate completion date of November 30, 2024 and enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic...
- The federal contract IDV award SPE2DX15D9145 is a single-award Indefinite Delivery Contract (IDC) granted by the Defense Logistics Agency (DLA) to the prime contractor, DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at up to $4,999,999, covers the delivery of a comprehensive range of pharmaceutical products and medical supplies, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the...
- The federal contract IDV award SPE2DX16D9930 is a single-award Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $4,999,999.99, was awarded by the Defense Logistics Agency (DLA) and is valid through December 31, 2025. Under this IDC, DMS Pharmaceutical Group Inc. provides a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military...
- The federal contract IDV award SPE2DX16D9957 is a single-award Indefinite Delivery Contract (IDC) valued at $4,999,999.00 and awarded to the woman-owned small business DMS Pharmaceutical Group Inc. by the Defense Logistics Agency (DLA) under the SPE2DX program. The contract covers the delivery of a comprehensive range of pharmaceutical products to support the medical supply needs of military health facilities worldwide, including branded and generic prescription drugs, over-the-counter...
- The federal contract IDV award SPE2DX15D9159 is a single-award Indefinite Delivery Contract (IDC) between the Defense Logistics Agency (DLA) and the prime contractor DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $4,999,999.00, covers the delivery of a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers...
- The federal contract IDV award SPE2DX15D9787 is a single-award Indefinite Delivery Contract (IDC) valued at up to $4,999,999.00, awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract's ultimate completion date is December 31, 2025, and it enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs,...
- The federal contract IDV award SPE2DX24D9950 is a single-award indefinite delivery contract (IDC) with a ceiling value of $499,999,999 issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, which runs through December 31, 2025, is part of the DLA's Medical Supply Chain program and allows the agency to issue firm fixed-price delivery orders for a wide range of pharmaceutical products to support the...
- The federal contract IDV award with ID SPE2DX15D9373 is a single-award Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $499,999,999 IDC, awarded by the Defense Logistics Agency (DLA) under the SPE2DB program, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The IDC covers an...
- The federal contract IDV award SPE2DR25D9957 is a single-award Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $4,999,999, was awarded by the Defense Logistics Agency (DLA) and is valid through December 2026. The purpose of this IDC is to enable DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs,...